I-Daclatasvir Dihydrochloride

Incazelo emfushane:

Igama le-API Inkomba Ukucaciswa I-US DMF I-EU DMF CEP
I-Daclatasvir Dihydrochloride I-HCV Endlini    


Imininingwane Yomkhiqizo

Omaka bomkhiqizo

IMINININGWANE YOMKHIQIZO

Incazelo

I-Daclatasvir dihydrochloride (BMS-790052 dihydrochloride) inamandla futhi isebenza ngomlomo.I-HCV NS5A amaprotheniinhibitor ngeEC50s uhla lwe-9-146 pM yeeziningi ze-HCV replicon genotypes.I-Daclatasvir dihydrochloride nayo iyi-ai-organic anion transporting polypeptide 1B (OATP1B)futhiI-OATP1B3inhibitor ngeIC50s ka-1.5 µM no-3.27 µM, ngokulandelanayo.

IC50& Okuqondiwe

EC50: 50 pM (HCV replicon genotype 1a), 9 pM (HCV replicon genotype 1b), 71 pM (HCV replicon genotype 2a), 146 pM (HCV replicon genotype 3a), 12 pM (HCV replicon genotype 34a) I-HCV replicon genotype 5a)[1]
I-Kd: 8 nM (NS5A33-202) kanye ne-210 nM (NS5A26-202)[2]
I-IC50: 1.5 µM (OATP1B) kanye ne-3.27 µM (OATP1B3)[3]

Ku-Vitro

I-Daclatasvir (BMS-790052) ibonisa umsebenzi onamandla wokuvimbela kuwo wonke ama-genotype ahloliwe, nge-EC50amanani asuka ku-9pm kuye ku-146 pM.I-Daclatasvir ivimbela i-HCV replicon genotype 1a, 1b, 2a, 3a, 4a kanye no-5a nge-EC50amanani 50 pM, 9 pM, 71 pM, 146 pM, 12 pM kanye 33 pM, ngokulandelana.I-Daclatasvir iyi-inhibitor enamandla ye-JFH-1 genotype 2a virus ethathelwanayo ephindaphinda isiko lamaseli (EC50=28pm)[1].I-Daclatasvir (BMS-790052) ibophezela ngokuqinile ku-NS5A33-202 kanye ne-NS5A26-202 ne-Kds ka-8 nM no-210 nM, ngokulandelana[2].

Isitoreji

Impushana

-20°C

3 iminyaka
 

4°C

iminyaka engu-2
Ku-solvent

-80°C

6 izinyanga
 

-20°C

Inyanga engu-1


Ukuhlolwa Komtholampilo

Inombolo ye-NCT Umxhasi Isimo Usuku okuqalwa ngalo

Isigaba

I-NCT03369327 I-Tehran University of Medical Sciences|RojanPharma Pharmaceutical Company Ukutheleleka Ngegciwane Le-Hepatitis C, Ukusabela Ekwelapheni ||Human Immunodeficiency Virus Januwari 1, 2017

Isigaba 3

I-NCT03485846 R-Pharm|Almedis I-Chronic Hepatitis C Genotype 1b Novemba 27, 2017

Isigaba 2

I-NCT01016912 I-Bristol-Myers Squibb Ukutheleleka kwe-Hepatitis C Disemba 2009

Isigaba 2

I-NCT01629732 I-Bristol-Myers Squibb I-Hepatitis C Virus Mashi 2013

Isigaba 2

I-NCT01497834 I-Bristol-Myers Squibb I-Hepatitis C Januwari 2012

Isigaba 3

I-NCT01973049 I-Bristol-Myers Squibb I-Hepatitis C Disemba 2013

Isigaba 3

I-NCT00663208 I-Bristol-Myers Squibb I-Hepatitis C engapheli Meyi 2008

Isigaba 2

I-NCT02576314 Humanity and Health Research Centre|Beijing 302 Hospital Ukutheleleka Kwe-Hepatitis C Okungapheli May 2015

Isigaba 3

I-NCT02756936 I-Genuine Research Center, Egypt|Zeta Pharma Pharmaceutical Industries Unempilo February 2016

Isigaba 1

I-NCT02771405 I-National Hepatology & Tropical Medicine Research Institute|Cairo University I-Hepatitis C, Engamahlalakhona | I-Hepatocellular Carcinoma Mashi 2016

Isigaba 3

I-NCT03706898 I-Viriom HIV-1-infection|Hepatic Impairment Okthoba 1, 2018

Isigaba 1

I-NCT02319031 I-Bristol-Myers Squibb I-Hepatitis C February 2015

Isigaba 3

I-NCT02124044 Izikhungo Zikazwelonke Zesikhungo Sezempilo Sezempilo (CC)|Isikhungo Sikazwelonke Sokungezwani Nezifo Nezifo Ezithathelwanayo (NIAID)|Bristol-Myers Squibb I-HIV-HCV February 2014

Isigaba 2

I-NCT02551861 I-Bristol-Myers Squibb I-Hepatitis C Disemba 2015

Isigaba 2

I-NCT00859053 I-Bristol-Myers Squibb Ukungasebenzi Kwesibindi Mashi 2009

Isigaba 1

I-NCT01257204 I-Bristol-Myers Squibb I-Hepatitis C Virus Disemba 2010

Isigaba 2

I-NCT03063879 I-Tehran University of Medical Sciences|Ahvaz Jundishapur University of Medical Sciences|Shiraz University of Medical Sciences|Hamadan University of Medical Science I-Hepatitis C, Okungamahlalakhona|Ukwehluleka Kwezinso Okungapheli Ephreli 1, 2017

Isigaba 4

I-NCT01017575 I-Bristol-Myers Squibb Ukutheleleka kwe-Hepatitis C Disemba 2009

Isigaba 2

I-NCT02865369 Sang Gyune Kim|Seoul National University Boramae Hospital|Severance Hospital|Inha University Hospital|Korea University|Gachon University Gil Medical Center|Hanyang University Seoul Hospital|Ewha Womans University Mokdong Hospital|Bristol-Myers Squibb|Soonchunhyang University Hospital I-Hepatitis C engapheli Septhemba 2016

I-NCT04070235 I-Nanjing Sanhome Pharmaceutical, Co., Ltd. I-Hepatitis C, Engamahlalakhona Mashi 29, 2019

Isigaba 2|Isigaba 3

I-NCT03487848 I-Bristol-Myers Squibb I-Hepatitis C | I-Hepatitis Engapheli Meyi 18, 2018

Isigaba 2

I-NCT00904059 I-Bristol-Myers Squibb I-Hepatitis C Meyi 2009

Isigaba 1

I-NCT02107365 I-French National Institute for Health and Medical Research-Isikhungo Sikazwelonke SaseFrance Socwaningo Lwengculazi kanye Nesifo Sesibindi Esibangelwa Amagciwane (Inserm-ANRS)|Bristol-Myers Squibb I-Hepatitis C Virus Genotype 4 Infection Novemba 2013

Isigaba 2

I-NCT02397395 Janssen R&D Ireland Ukukhubazeka Kwezinso|Isifo Sezinso Sokuphela May 2015

Isigaba 2

I-NCT03169348 Inyuvesi yase-Assiut I-Hepatitis C Novemba 1, 2017

Akufaneleki

I-NCT02323594 I-Bristol-Myers Squibb Ukutheleleka kwe-Hepatitis C Disemba 2014

Isigaba 1

I-NCT03537196 I-French National Institute for Health and Medical Research-Isikhungo Sikazwelonke SaseFrance Socwaningo Lwengculazi kanye ne-Viral Hepatitis (Inserm-ANRS) I-Hepatitis C|Ukusetshenziswa Kwezidakamizwa|I-Viral Hepatitis C Novemba 13, 2018

Isigaba 4

I-NCT02103569 I-Bristol-Myers Squibb I-Hepatitis C Ephreli 2014

Isigaba 1

I-NCT02772744 Inyuvesi yaseZagazig | Inyuvesi yaseCairo I-Hepatitis C Novemba 1, 2017

I-NCT01718158 I-Bristol-Myers Squibb I-Hepatitis C Januwari 2013

Isigaba 3

I-NCT02496078 I-Bristol-Myers Squibb I-Hepatitis C Agasti 2015

Isigaba 3

I-NCT01425970 I-Bristol-Myers Squibb I-Hepatitis C Meyi 2012

Isigaba 2

I-NCT01471574 I-Bristol-Myers Squibb I-Hepatitis C, i-Genotype 1 Disemba 2011

Isigaba 3

I-NCT01573351 I-Bristol-Myers Squibb I-Hepatitis C Virus Meyi 2012

Isigaba 3

I-NCT01938625 Janssen R&D Ireland I-Hepatitis C, Engamahlalakhona Disemba 12, 2013

Isigaba 2

I-NCT01492426 I-Bristol-Myers Squibb I-Hepatitis C Januwari 2012

Isigaba 3

I-NCT03480932 Johns Hopkins Bloomberg School of Public Health|National Institute on Drug Abuse (NIDA)|YR Gaitonde Centre for AIDS Research and Education I-Hepatitis C, Engamahlalakhona Februwari 2, 2018

Isigaba 2|Isigaba 3

I-NCT03163849 Inyuvesi yase-Assiut Isifo Sesibindi Esingamahlalakhona c Septhemba 1, 2019

Isigaba 3

I-NCT01581203 I-Bristol-Myers Squibb I-Hepatitis C Virus Meyi 2012

Isigaba 3

I-NCT01492504 I-Bristol-Myers Squibb I-Hepatitis C Februwari 7, 2012

I-NCT03686722 Mohamed Raslan|Ain Shams University|Isikhungo Sokucwaninga Ngezidakamizwa, eCairo, Egypt Isifo sikashukela i-mellitus, Uhlobo 2|Hepatitis C|Ukusebenzelana Nezidakamizwa Septhemba 9, 2017

Isigaba 1

I-NCT02262728 Janssen Research & Development, LLC I-Hepatitis C, Engamahlalakhona Septhemba 30, 2014

Isigaba 2

I-NCT02349048 Janssen Research & Development, LLC I-Hepatitis C Virus Januwari 2015

Isigaba 2

I-NCT03882307 Inyuvesi yase-Assiut I-Hepatitis C, Engamahlalakhona Meyi 2020

Isigaba sokuqala 1

I-NCT02758509 I-Parc de Salut Mar I-Chronic Hepatitis C|Cirrhosis Januwari 1, 2010

I-NCT01795911 I-Bristol-Myers Squibb I-Hepatitis C Mashi 2013

Isigaba 2

I-NCT03549832 I-Assiut University|Sohag University|South Valley University I-HCV Coinfection Januwari 1, 2018

Akufaneleki

I-NCT02161939 I-Bristol-Myers Squibb I-Hepatitis C engapheli  

I-NCT01309932 I-Bristol-Myers Squibb I-Hepatitis C Mashi 2011

Isigaba 2

I-NCT01995266 I-Bristol-Myers Squibb I-Hepatitis C Februwari 28, 2014

Isigaba 3

I-NCT02640157 AbbVie I-Chronic Hepatitis C|Virus ye-Hepatitis C|Genotype 3 Igciwane Le-Hepatitis C Disemba 2015

Isigaba 3

I-NCT02032875 I-Bristol-Myers Squibb I-Hepatitis C Mashi 2014

Isigaba 3

I-NCT02624063 I-Federal University yaseSão Paulo I-Hepatitis C, Engamahlalakhona Disemba 2015

Isigaba 4

I-NCT00546715 I-Bristol-Myers Squibb I-Hepatitis C engapheli Novemba 2007

Isigaba 1|Isigaba 2

I-NCT01718145 I-Bristol-Myers Squibb Ukutheleleka nge-Hepatitis C Virus Novemba 2012

Isigaba 3

I-NCT01616524 I-Bristol-Myers Squibb I-Hepatitis C Virus (HCV) Julayi 2012

Isigaba 3

I-NCT02032901 I-Bristol-Myers Squibb I-Hepatitis C Januwari 2014

Isigaba 3

I-NCT03540212 Inyuvesi yase-Ain Shams Ukutheleleka kwe-HCV okungapheli Disemba 10, 2017

Isigaba 2|Isigaba 3

I-NCT02097966 I-Bristol-Myers Squibb I-Hepatitis C engapheli  

I-NCT02596880 I-Tehran University of Medical Sciences IHepatitis C|Cirrhosis Septhemba 2015

Isigaba 3

I-NCT04019717 Inkampani Atea Pharmaceuticals, Inc. I-Hepatitis C|I-Hepatitis C, Engalapheki|I-Hepatitis C Engapheli|Ukutheleleka Ngegciwane Le-Hepatitis C|Ukutheleleka kwe-HCV Juni 20, 2019

Isigaba 2

I-NCT02992457 Inyuvesi yaseTanta I-Hepatitis C Januwari 2015

Isigaba 4

I-NCT03547895 Inyuvesi yaseZagazig I-Decompensated Cirrhosis Juni 1, 2015

Akufaneleki

I-NCT03004625 Isibhedlela sase-Kaohsiung Medical University i-Chung-Ho Memorial Hospital|Isibhedlela i-Chang Gung Memorial|Isibhedlela Sikazwelonke sase-Taiwan University|Isibhedlela Sikazwelonke Sase-Taipei Veterans, e-Taiwan|Isibhedlela sase-China Medical University|Isibhedlela Sikazwelonke sase-Cheng-Kung University I-Hepatitis C Novemba 2016

Isigaba 3

I-NCT01051414 I-Bristol-Myers Squibb Ukutheleleka kwe-Hepatitis C Ephreli 2010

Isigaba 2

I-NCT02309450 I-French National Institute for Health and Medical Research-Isikhungo Sikazwelonke SaseFrance Socwaningo Lwengculazi kanye Nesifo Sesibindi Esibangelwa Amagciwane (Inserm-ANRS)|Bristol-Myers Squibb I-Hepatitis C Virus Genotype 4 Infection Disemba 2014

Isigaba 2

I-NCT01628692 Bristol-Myers Squibb|Janssen Research & Development, LLC I-Hepatitis C Virus Julayi 2012

Isigaba 2

I-NCT03186313 Isibhedlela sesibindi sase-Egypt | Isibhedlela i-Wadi El Nil I-Hepatitis C Septhemba 2016

Isigaba 3

I-NCT03063723 Isibhedlela Sesithathu Esihlobene, i-Sun Yat-Sen University I-Hepatitis C Engamahlalakhona (Ukukhubazeka) Januwari 1, 2016

I-NCT00983957 I-Bristol-Myers Squibb I-Hepatitis C engapheli Okthoba 2009

Isigaba 1

I-NCT01725542 I-French National Institute for Health and Medical Research-Isikhungo Sikazwelonke SaseFrance Socwaningo Lwengculazi kanye Nesifo Sesibindi Esibangelwa Amagciwane (Inserm-ANRS)|Bristol-Myers Squibb I-HCV-HIV Co-Infection Disemba 2012

Isigaba 2

I-NCT02282709 Isisekelo Socwaningo Lwesibindi I-Hepatitis C engapheli February 2014

Isigaba 3

I-NCT02032888 I-Bristol-Myers Squibb I-Hepatitis C February 2014

Isigaba 3

I-NCT03247296 Inyuvesi ye-MTI I-Hepatitis C February 28, 2017

I-NCT01389323 I-Bristol-Myers Squibb I-Hepatitis C Septhemba 2011

Isigaba 3

I-NCT02556086 I-Bristol-Myers Squibb I-Hepatitis C Disemba 2015

Isigaba 2

I-NCT01741545 I-Bristol-Myers Squibb I-Hepatitis C Virus Mashi 31, 2013

Isigaba 3

I-NCT01866930 I-Bristol-Myers Squibb Ukutheleleka Kwe-Hepatitis C Okungapheli Julayi 11, 2013

Isigaba 3

I-NCT02268864 Izindleko zamasheya Janssen-Cilag International NV I-Hepatitis C, Engamahlalakhona Januwari 2015

Isigaba 2

I-NCT01797848 I-Bristol-Myers Squibb I-Hepatitis C Juni 2014

Isigaba 3

I-NCT03166280 Eman Sayed Hassan Abd Allah|Assiut University I-Hepatitis C Juni 2017

I-NCT02159352 I-Bristol-Myers Squibb I-Hepatitis C Juni 2014

Isigaba 1

I-NCT01125189 I-Bristol-Myers Squibb I-Hepatitis C Virus Julayi 2010

Isigaba 2

I-NCT03748745 I-Nanjing Sanhome Pharmaceutical, Co., Ltd. Ukusebenzisana Kwezidakamizwa Novemba 19, 2018

Isigaba 1

I-NCT01012895 I-Bristol-Myers Squibb I-Hepatitis C engapheli Disemba 2009

Isigaba 2

I-NCT02565888 Inyuvesi yaseRadboud I-Hepatitis C | I-HIV Novemba 2015

Isigaba 1

I-NCT02555943 Humanity and Health Research Centre|Beijing 302 Hospital|Nanfang Hospital of Southern Medical University Ukutheleleka Kwe-Hepatitis C Okungamahlalakhona|I-HBV Coinfection|Ukuvuselelwa Kwe-Hepatitis B February 2015

Isigaba 2|Isigaba 3

I-NCT02304159 Tarek I. Hassanein, MD, FACP, FAG, AGAF|Southern California Research Center IHepatitis C|Cirrhosis Januwari 2015

Isigaba 4

I-NCT02580474 Myeong Jun Song|Bristol-Myers Squibb|Soonchunhyang University Hospital|Dankook University|Chungnam National University Hospital|Konyang University Hospital|Eulji University Hospital|Saint Vincent's Hospital, Korea|Konkuk University Hospital|Cheongju St. Mary's Hospital, Cheongju , Korea|Severance Hospital|Korea University Guro Hospital|Eulji General Hospital|The Catholic University of Korea I-Hepatitis C February 2016

Isigaba 4

I-NCT02104843 I-Bristol-Myers Squibb I-Hepatitis C Ephreli 2014

Isigaba 1

I-NCT01428063 I-Bristol-Myers Squibb Ukutheleleka nge-Hepatitis C Virus Septhemba 2011

Isigaba 2

I-NCT02123654 I-Bristol-Myers Squibb Ukutheleleka nge-Hepatitis C Virus Ephreli 2014

Isigaba 3

I-NCT02565862 Inyuvesi yaseRadboud IHepatitis C|Diabetes Mellitus|Ukumelana ne-insulin Januwari 2016

Isigaba 1

I-NCT04211844 Inyuvesi yase-Ain Shams I-Hepatitis C engapheli Okthoba 1, 2019

I-NCT00874770 I-Bristol-Myers Squibb Ukutheleleka kwe-Hepatitis C Juni 2009

Isigaba 2

I-NCT03883698 I-Sanjay Gandhi Postgraduate Institute of Medical Sciences Ukwehluleka Kwezinso, Okungapheli|I-Hepatitis C Mashi 15, 2019

Isigaba 3

I-NCT01448044 I-Bristol-Myers Squibb I-Hepatitis C Disemba 2011

Isigaba 3

I-NCT01359644 Bristol-Myers Squibb|Pharmasset I-Hepatitis C engapheli Juni 2011

Isigaba 2

I-NCT01842451 I-Vertex Pharmaceuticals Incorporated IHepatitis C|CHC|HCV|Hepatitis C Juni 2013

Isigaba 2

I-NCT02762448 Isibhedlela sikaMasipala waseTainan I-Hepatitis c Julayi 2016

I-NCT02473211 Humanity and Health Research Centre|Beijing 302 Hospital Ukutheleleka Kwe-Hepatitis C Okungapheli Januwari 2015

Isigaba 2|Isigaba 3

I-NCT01455090 I-Bristol-Myers Squibb I-Hepatitis C engapheli Novemba 30, 2011

Isigaba 2

I-NCT03490097 Inyuvesi yase-Ain Shams IHepatitis C|Metabolic Syndrome Disemba 1, 2017

Isigaba 2|Isigaba 3

I-NCT01170962 I-Bristol-Myers Squibb I-Hepatitis C Virus Agasti 2010

Isigaba 2

I-NCT02333292 Isibhedlela i-Valme University|Isibhedlela del SAS de Jerez|Isibhedlela I-General Universitario Elche|Isibhedlela La Línea de la Concepción|Complexo Hospitalario Universitario de A Coruña|Isibhedlela de Figueres|Isibhedlela Universitario Puerto Real|Isibhedlela Universitario Virgen de laversitare Isibhedlela General Universitario de Alicante|Isibhedlela Universitario Araba|Isibhedlela Royo Vilanova|Isibhedlela Universitario de Burgos|Complejo Hospitalario Universitario de Huelva|Isibhedlela Universitario Reina Sofia de Cordoba|Isibhedlela Universitario Virgen Macarena | Navarra|Hospital Clinico Universitario San Cecilio|Isibhedlela Universitario La Fe|Isibhedlela General Universitario de Valencia|Isibhedlela Universitario Infanta Leonor|Isibhedlela Universitario de Gran Canaria|Isibhedlela I-General Universitario Santa Lucía|Centro Penitenciario Isibhedlela I-Alicante de Alicario la Luz|Isibhedlela Jikelele Universitario de Castellón|Isibhedlela uParc Taulí, Sabadell Ukutheleleka Kwe-Hepatitis C Okungapheli Disemba 2014

I-NCT03200184 I-Tehran University of Medical Sciences I-Hepatitis C Septhemba 1, 2016

Isigaba 4

I-NCT03188276 Isibhedlela Sesithathu Esihlobene, i-Sun Yat-Sen University I-Hepatitis C engapheli Februwari 1, 2016

Isigaba sokuqala 1

I-NCT01830205 I-Bristol-Myers Squibb I-Hepatitis C Septhemba 2012

Isigaba 1

 

ISItifiketi

2018 GMP-2
原料药GMP证书201811(captopril ,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

UKUPHATHWA KWEKHWALITHI

Quality management1

Isiphakamiso18Amaphrojekthi Wokuhlola Ukuvumelana Kwekhwalithi asegunyaziwe4, futhi6amaphrojekthi angaphansi kokugunyazwa.

Quality management2

Uhlelo lokuphatha ikhwalithi yamazwe ngamazwe oluthuthukile lwenze isisekelo esiqinile sokuthengisa.

Quality management3

Ukugadwa kwekhwalithi kusebenza kuwo wonke umjikelezo wempilo womkhiqizo ukuze kuqinisekiswe ikhwalithi nomphumela wokwelapha.

Quality management4

Ithimba Lezindaba Zokulawula Ochwepheshe lisekela izimfuno zekhwalithi ngesikhathi sokufaka isicelo nokubhaliswa.

UKUPHATHWA KOMKHIQIZO

cpf5
cpf6

I-Korea Countec Bottled Packaging Line

cpf7
cpf8

I-Taiwan CVC Bottled Packaging Line

cpf9
cpf10

I-Italy CAM Board Packaging Line

cpf11

Umshini Wokuhlanganisa we-Fette waseJalimane

cpf12

I-Japan Viswill Tablet Detector

cpf14-1

I-DCS Control Room

UZAkwethu

Ukubambisana kwamazwe ngamazwe
International cooperation
Ukubambisana kwasekhaya
Domestic cooperation

  • Okwedlule:
  • Olandelayo:

  • Bhala umlayezo wakho lapha futhi usithumelele wona